Barclays Cuts Pacific Biosciences of California (NASDAQ:PACB

Barclays Cuts Pacific Biosciences of California (NASDAQ:PACB) Price Target to $3.00

Barclays Cuts Pacific Biosciences of California (NASDAQ:PACB) Price Target to $3.00

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Blackrock , California , United States , Pacific Biosciences , Oene Mark Van , Davidw Meline , Investment Management , California Inc , California Company Profile , Wolfe Research , Blackrock Inc , Pricet Rowe Associates Inc , Vanguard Group Inc , Barclays , Capital International Investors , Free Report , California Stock , Get Free Report , Director David , Funds Weigh In On Pacific Biosciences , International Investors , Pricet Rowe Associates , California Company , California Daily ,